NDM型碳青霉烯酶肠杆菌侧流免疫层析检测方法的开发与验证
研究开发并评估了一种侧流免疫层析法(LFIA),用于从培养菌落中快速检测产NDM样碳青霉烯酶的肠杆菌。使用175株参考菌株和74株临床分离株验证,所有27株NDM样生产者均被正确检出(<15分钟),敏感性和特异性均为100%,无交叉反应。该方法快速、简便,适合临床微生物实验室常规确认。
要点
- NDM LFIA可在15分钟内从培养菌落中检出NDM样碳青霉烯酶。
- 对参考菌株和临床分离株的敏感性和特异性均为100%。
- 与其它碳青霉烯酶、ESBLs、AmpCs和oxacillinases无交叉反应。
核心结论
- NDM LFIA是一种高效、快速、易于在临床微生物实验室常规工作流程中实施的工具,可用于确认产NDM样碳青霉烯酶的肠杆菌。
研究设计与样本
- 研究使用175株已知β-内酰胺酶基因内容的参考肠杆菌分离株和74株2016年6月一周内转诊至法国国家抗生素耐药参考中心的非重复连续碳青霉烯耐药临床分离株进行评估。
主要发现
- 参考集合中所有27株NDM样碳青霉烯酶生产者均在15分钟内被正确检出,包括22株产NDM-1、2株产NDM-4、1株产NDM-5、1株产NDM-7和1株产NDM-9。
- 所有非NDM-1生产者用NDM LFIA检测均为阴性。
- 与碳青霉烯酶(VIM、IMP、NDM、KPC和OXA-48样)、超广谱β-内酰胺酶(TEM、SHV和CTX-M)、AmpC酶(CMY-2、DHA-2和ACC-1)及oxacillinases(OXA-1、-2、-9和-10)均未观察到交叉反应。
- 在74株转诊的非重复连续临床分离株中,所有7株NDM样生产者均被鉴定。
- 总体上,对于琼脂培养菌株,该检测方法检测NDM样碳青霉烯酶的敏感性和特异性均为100%。
关键数值与推荐
- NDM LFIA检测NDM样碳青霉烯酶的敏感性和特异性均为100%(基于琼脂培养菌株)。
- 所有27株NDM样碳青霉烯酶生产者在15分钟内被正确检出。
临床怎么用
- NDM LFIA可用于临床微生物实验室常规工作流程中从培养菌落快速确认产NDM样碳青霉烯酶的肠杆菌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The global spread of carbapenemase-producing Enterobacteriaceae (CPE) that are often resistant to most, if not all, classes of antibiotics is a major public health concern. The NDM-1 carbapenemase is among the most worrisome carbapenemases given its rapid worldwide spread. We have developed and evaluated a lateral flow immunoassay (LFIA) (called the NDM LFIA) for the rapid and reliable detection of NDM-like carbapenemase-producing Enterobacteriaceae from culture colonies. We evaluated the NDM LFIA using 175 reference enterobacterial isolates with characterized β-lactamase gene content and 74 nonduplicate consecutive carbapenem-resistant clinical isolates referred for expertise to the French National Reference Center (NRC) for Antibiotic Resistance during a 1-week period (in June 2016). The reference collection included 55 non-carbapenemase producers and 120 carbapenemase producers, including 27 NDM producers. All 27 NDM-like carbapenemase producers of the reference collection were correctly detected in less than 15 min by the NDM LFIA, including 22 strains producing NDM-1, 2 producing NDM-4, 1 producing NDM-5, 1 producing NDM-7, and 1 producing NDM-9. All non-NDM-1 producers gave a negative result with the NDM LFIA. No cross-reaction was observed with carbapenemases (VIM, IMP, NDM, KPC, and OXA-48-like), extended-spectrum β-lactamases (ESBLs) (TEM, SHV, and CTX-M), AmpCs (CMY-2, DHA-2, and ACC-1), and oxacillinases (OXA-1, -2, -9, and -10). Similarly, among the 74 referred nonduplicate consecutive clinical isolates, all 7 NDM-like producers were identified. Overall, the sensitivity and specificity of the assay were 100% for NDM-like carbapenemase detection with strains cultured on agar. The NDM LFIA was efficient, rapid, and easy to implement in the routine workflow of a clinical microbiology laboratory for the confirmation of NDM-like carbapenemase-producing Enterobacteriaceae.
引用
- Boutal H, Naas T, Devilliers K, et al. Development and Validation of a Lateral Flow Immunoassay for Rapid Detection of NDM-Producing Enterobacteriaceae. J Clin Microbiol. 2017. PMID: 28404680. doi:10.1128/JCM.00248-17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。